In this special episode filmed in Paris at EURETINA 2025, I am joined by Professor Gemmy Cheung, Professor and Senior Consultant Ophthalmologist at the Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, and my fellow Vision Academy and Barometer Program. 

Join us as we explore current guidance for the diagnosis and management of simultaneous geographic atrophy (GA) and choroidal/macular neovascularization (CNV/MNV) in clinical practice from the Vision Academy’s viewpoint. In this episode, Gemmy and I dive into insights from published literature on the clinical profile and pathophysiology of the disease and the recommendations from the Vision Academy for the diagnosis and management of simultaneous GA and CNV/MNV. Finally, we discuss the more sophisticated multimodal imaging we use in our clinics, including OCT-A and fundus autofluorescence. 

To learn more about clinical characteristics and underlying mechanisms of simultaneous GA and CNV/MNV, read the Vision Academy Viewpoint and publication on the incidence, characteristics, and treatments for simultaneous GA and CNV/MNV. For more information about patient-focused care, visit the nAMD Barometer and DR Barometer websites.

If you enjoyed this episode, SUBSCRIBE to “A Chat with Anat” to make sure you never miss an episode! 

Speaker disclosures:

Professor Anat Loewenstein

Consultant: 4DMT, AbbVie, Astellas, Bayer, Beyeonics, Eyepoint, Notal Vision, Ocular Therapeutix, Ocuphire, Oculis, Opthea, Roche, Boehringer-Ingelheim, Aviceda, Voiant

Professor Gemmy Cheung

Consulting fees, speaker fees, and grants: Avirmax, Bayer, Boehringer Ingelheim, Iveric, Janssen, Iveric, Janssen, Novartis, Roche, Topcon, and Zeiss.

November 2025 | PP-PF-OPHT-ALL-0248-1

This podcast series is intended for HCPs, and is not intended for UK audiences.

Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing.

This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.

The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.

The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.